China Resources Jiangzhong Pharmaceutical Co 600750.SS · CNY
Health Care · Shanghai · 🇨🇳 China
23.20
-0.04%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About China Resources Jiangzhong Pharmaceutical Co
Its shares trade on Shanghai under the ticker 600750.SS. It has been listed since 23 September 1996. In the fiscal year to 31 December 2025, it reported revenue of CN¥4.22bn and net income of CN¥906.1m. At that date it held total assets of CN¥6.88bn and shareholders' equity of CN¥4.02bn.
Jiangzhong Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Nanchang, Jiangxi. The Company’s products include OTC medicines, healthcare products and functional food, as well as wine. Its OTC pharmaceuticals include indigestion tablets, lactobacillin tablets and sarcandra glabra tablets, among others. Its healthcare products and functional food include calcium tablets and ginseng products, among others. The firm mainly operates its businesses in domestic market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 23 Sept 1996
- Employees
- 4,018
- Website
- jzjt.com ↗
Leadership
Pay as last reported
- Mr. Weiquan LiuChairman of the Board, since 2002CN¥1,000
- Mr. Xiaojun LiChief Financial OfficerCN¥447,700
- Mr. Wenbin XiaoGeneral ManagerCN¥1.4m
- Ms. Yongjing TianSecretary of the BoardCN¥396,500
- Mr. Xingpin CuiDirector
- Ms. Rong DengDirector
- Mr. Fengxiang HuDirector
- Mr. Lixin LiuDirector
- Mr. Yongqian XuDirector, since 2015
- Mr. Bo LiangIndependent Director
- Mr. Henghua XieIndependent Director
- Mr. Yan ZhangIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Jiangzhong Pharmaceutical employs 4018 employees in Nanchang, CN, strengthening its domestic market presence.
- The company manufactures OTC medicines like indigestion tablets and lactobacillin tablets for the domestic market.
- Jiangzhong's product portfolio includes calcium tablets, ginseng products, and functional food for healthcare segments.
Weaknesses
- Jiangzhong Pharmaceutical's business is limited to the domestic market in China, restricting international growth.
- The company's reliance on OTC pharmaceuticals may limit diversification in the Health Care sector.
- Jiangzhong's operations are concentrated in Nanchang, Jiangxi, potentially increasing regional dependency risks.
Opportunities
- Expanding OTC medicine distribution to other regions within China could increase market share.
- Introducing new functional food products could attract more consumers in the domestic health segment.
- Growing demand for ginseng products in China presents a significant opportunity for Jiangzhong.
Threats
- Competition from domestic pharmaceutical companies in China could impact Jiangzhong's market position.
- Regulatory changes in the Chinese pharmaceutical industry might affect Jiangzhong's operations.
- Economic downturns in China could reduce consumer spending on OTC medicines and functional food.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.